Venus Concept Inc (VERO) - Total Liabilities
Based on the latest financial reports, Venus Concept Inc (VERO) has total liabilities worth $58.49 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore VERO shareholders equity momentum to track the company's year-over-year net asset growth rate.
Venus Concept Inc - Total Liabilities Trend (2015–2024)
This chart illustrates how Venus Concept Inc's total liabilities have evolved over time, based on quarterly financial data. See Venus Concept Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Venus Concept Inc Competitors by Total Liabilities
The table below lists competitors of Venus Concept Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
S2Medical AB
ST:S2M
|
Sweden | Skr6.90 Million |
|
System1 Group PLC
LSE:SYS1
|
UK | GBX6.08 Million |
|
EPWK Holdings Ltd. Class A Ordinary Shares
NASDAQ:EPWK
|
USA | $12.19 Million |
|
Zinnwald Lithium PLC
LSE:ZNWD
|
UK | GBX2.20 Million |
|
Manz AG
F:M5Z
|
Germany | €177.01 Million |
|
PCI-PAL PLC
LSE:PCIP
|
UK | GBX17.02 Million |
|
Redan S.A.
WAR:RDN
|
Poland | zł34.54 Million |
|
Discovery-Corp Enterprises Inc.
V:DCY
|
Canada | CA$36.38K |
Liability Composition Analysis (2015–2024)
This chart breaks down Venus Concept Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Venus Concept Inc (VERO) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.90 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 21.88 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.95 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Venus Concept Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Venus Concept Inc (2015–2024)
The table below shows the annual total liabilities of Venus Concept Inc from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $65.35 Million | -38.99% |
| 2023-12-31 | $107.10 Million | -8.18% |
| 2022-12-31 | $116.64 Million | +0.75% |
| 2021-12-31 | $115.78 Million | -0.85% |
| 2020-12-31 | $116.76 Million | +2.02% |
| 2019-12-31 | $114.45 Million | +289.40% |
| 2018-12-31 | $29.39 Million | +48.62% |
| 2017-12-31 | $19.78 Million | -87.87% |
| 2016-12-31 | $163.04 Million | +9.66% |
| 2015-12-31 | $148.68 Million | -- |
About Venus Concept Inc
Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-app… Read more